Close

Analyst Ratings for Inotek Pharmaceuticals (ITEK) [Buys]

ITEK Rating Summary

  |   Expand Research on ITEK
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 5 / 10   Percentile Rank: 53%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/1/2016 Roth/MKM N/A New Coverage Buy
(N/A)
10.00
(N/A)
6.40
(3.04)
-52.5% Details
3/16/2015 TD Cowen
» Updated 7/23/2015
N/A New Coverage Buy
(N/A)
40.00
(15.00)
5.69
(3.04)
-46.57% Details